The many faces of oxytocin: Implications for psychiatry

Psychiatry Research

Volumn 226, Issue 1, 2015, Pages 31-37

  Zik, Jodi B ^a   Roberts, David L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Autism; Intranasal; Moderators; Schizophrenia; Social cognition

Indexed keywords

OXYTOCIN; OXYTOCIN RECEPTOR; PLACEBO; OXYTOCIC AGENT;

AMYGDALOID NUCLEUS; AUTISM; BORDERLINE STATE; COGNITIVE BIAS; DRUG MECHANISM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENERALIZED ANXIETY DISORDER; GENETIC PREDISPOSITION; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; POLYDIPSIA; PRIORITY JOURNAL; PSYCHIATRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SIGNAL DETECTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL COGNITION; SOCIAL INTERACTION; TRANQUILIZING ACTIVITY; TREATMENT OUTCOME; COGNITION; DRUG EFFECTS; MENTAL DISORDERS; PHYSIOLOGY; PSYCHOLOGY; SOCIAL BEHAVIOR; STANDARDS; TRENDS;

COGNITION; HUMANS; MENTAL DISORDERS; OXYTOCICS; OXYTOCIN; PSYCHIATRY; SCHIZOPHRENIA; SOCIAL BEHAVIOR;

EID: 84926155541     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.11.048     Document Type: Review

References (103)

1. Adolphs R. What does the amygdala contribute to social cognition?. Cognitive Neuroscience 2010, 1191(1):42-61.
2. Alvares G.A., Hickie I.B., Guastella A.J. Acute effects of intranasal oxytocin on subjective and behavioral responses to social rejection. Experimental and Clinical Psychopharmacology 2010, 18:316-321.
3. Anagnostou E., Soorya L., Chaplin W., Bartz J., Halpern D., Wasserman S., Wang A.T., Pepa L., Tanel N., Kushki A., Hollander E. Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. Molecular Autism 2012, 3(1):16.
4. Anagnostou E., Soorya L., Brian J., Dupuis A., Mankad D., Smile S., Jacob S. Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth. Brain Research 2014, 1580:188-198.
5. Andari E., Duhamel J.R., Zalla T., Herbrecht E., Leboyer M., Sirigu A. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(9):4389-4394.
6. Andari E., Schneider F.C., Mottolese R., Vindras P., Sirigu A. Oxytocin's fingerprint in personality traits and regional brain volume. Cerebral Cortex 2012, 24(2):479-486.
7. Archer R. Chemistry of the Neurohypophyseal Hormones: An Example of Molecular Evolution. Handbook of Physiology 1974, 4:119-130. American Physiological Society, Washington, DC.
8. Arletti R., Bertolini A. Oxytocin acts as an antidepressant in two animal models of depression. Life Science 1987, 41:1725-1730.
9. Averbeck B.B. Oxytocin and the salience of social cues. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:9033-9034.
10. Bale T.L., Davis A.M., Auger A.P., Dorsa D.M., McCarthy M.M. CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. Journal of Neuroscience 2001, 21:2546-2552.
11. Bales K.L., Perkeybile A.M., Conley O.G., Lee M.H., Guoynes C.D., Downing G.M., Yun C.R., Solomon M., Jacob S., Medoza S.P. Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles. Biological Psychiatry 2013, 74:180-188.
12. Bartz J.A. Oxytocin selectively improves empathic accuracy. Psychological Science 2010, 21:1426-1428.
13. Bartz J.A., Simeon D., Hamilton H., Kim S., Crystal S., Braun A., Vicens V., Hollander E. Oxytocin can hinder trust and cooperation in borderline personality disorder. Social Cognitive and Affective Neuroscience 2010, 6(5):556-563.
14. Bartz J.A., Zaki J., Ochsner K.N. Social effects of oxytocin in humans: context and person matter. Trends in Cognitive Sciences 2011, 15:301-309.
15. Benarroch E.E. Oxytocin and vasopressin: social neuropeptides with complex neuromodulatory functions. Neurology 2013, 80:1521-1528.
16. Bernstein D.P., Stein J.A., Newcomb M.D., Walker E., Pogge D., Ahluvalia T., Zule W. Development and validation of a brief screening version of the childhood trauma questionnaire. Child Abuse and Neglect 2003, 27(2):169-190.
17. Bertsch K., Gamer M., Schimdt B., Schmidiner I., Walther S., Kastel T., Schnell K., Buchel C., Domes G., Herpetz S.C. Oxytocin and reduction of social threat hypersensitivity in women with borderline personality disorder. American Journal of Psychiatry 2013, 170(10):1169-1177.
18. Bowlby J. Attachment and Loss 1969, Basic Books, New York. 2nd ed.
19. Bralet M.C., Ton T., Falissard B. Schizophrenic patients with polydipsia and water intoxication more often have a form of schizophrenia first described by Kraepelin. Psychiatry Research 2007, 152:267-271.
20. Brothers L. The social brain: a project for integrating primate behavior and neurophysiology in a new domain. Concepts in Neuroscience 1990, 1:27-61.
21. Brunet-Gouet E., Decety J. Social brain dysfunctions in schizophrenia: a review of neuroimaging studies. Psychiatry Research 2006, 148:75-92.
22. Chen F.S., Kumsta R., von Dawans B., Monakhov M., Ebstein R.P., Heinrichs M. Common oxytocin receptor gene (OXTR) polymorphism and social support interact to reduce stress in humans. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:19937-19942.
23. Cheng S.W., North W.G. Absence of negative feedback by oxytocin on release from magnocellular neurones in conscious rats. Canadian Journal of Physiology and Pharmocology 1992, 70:100-105.
24. Churchland P.S., Winkielman P. Modulating social behavior with oxytocin: how does it work? What does it mean?. Hormones and Behavior 2012, 61:392-399.
25. Combs D.R., Penn D.L., Chadwick P., Trower P., Michael C.O., Basso M.R. Subtypes of paranoia in a nonclinical sample. Cognitive Neuropsychiatry 2007, 12(6):537-553.
26. Couture S.M., Penn D.L., Roberts D.L. The functional significance of social cognition in schizophrenia: a review. Schizophrenia Bulletin 2006, 32:S44-S63.
27. Curley J.P., Jensen C.L., Mashoodh R., Champagne F.A. Social influences on neurobiology and behavior: epigenetic effects during development. Psychoneuroendocrinology 2011, 36:352-371.
28. Dadds M.R., MacDonald E., Cauchi A., Williams K., Levy F., Brennan J. Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial. Journal of Autism and Developmental Disorders 2014, 44(3):521-531.
29. Davis M.C., Lee J., Horan W.P., Clarke A.D., McGee M.R., Green M.F., Marder S.R. Effects of single dose intranasal oxytocin on social cognition in schizophrenia. Schizophrenia Research 2013, 147(2-3):393-397.
30. De Dreu C.K.W., Greer L.L., Van Kleef G.A., Shalvi S., Handgraaf M.J.J. Oxytocin promotes human ethnocentrism. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(4):1262-1266.
31. De Dreu C.K.W., Greer Lindred L., Handgraaf Michel J.J., Shalvi Shaul, Van Kleef Gerben A., Baas Matthijs, Ten Velden Femke S., Van Dijk Eric, Feith, Sander W.W. Neuropeptide oxytocin regulates parochial altruism in intergroup conflicts among humans. Science 2010, 328:1408-1411.
32. De Leon J., Verghese C., Tracy J.I., Josiassen R.C., Simpson G.M. Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biological Psychiatry 1994, 35:408-419.
33. Declerck C.H., Boone C., Kiyonari T. Oxytocin and cooperation under conditions of uncertainty: the modulating role of incentives and social information. Hormones and Behavior 2010, 57:368-374.
34. Delva N.J., Crammer J.L., Lawson J.S., Lightman S.L., Sribney M., Weier B.J. Vasopressin in chronic psychiatric patients with primary polydipsia. British Journal of Psychiatry 1990, 157:703-712.
35. de Oliveira D.C.G., Zuardi A.W., Graeff F.G., Queiroz R.H.C., Crippa J.A.S. Anxiolytic-like effect of oxytocin in the simulated public speaking test. Journal of Psychopharmacology 2012, 26:2012.
36. Di Simplicio M., Massey-Chase R., Cowen P., Harmer C. Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers. Journal of Psychopharmacology 2009, 23:241-248.
37. Ditzen B., Schaer M., Bodenmann G., Gabriel B., Ehlert U., Heinrichs M. Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biological Psychiatry 2009, 65:728-731.
38. Domes G., Heinrichs M., Glascher J., Buchel C., Braus Dieter F., Herpertz S.C. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biological Psychiatry 2007, 62:1187-1190.
39. Domes G., Heinrichs M., Michel A., Berger C., Herpertz S.C. Oxytocin improves "mind-reading" in humans. Biological Psychiatry 2007, 61:731-733.
40. Domes G., Lischke A., Berger C., Grossmann A., Hauenstein K., Heinrichs M., Herpertz S.C. Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology 2010, 35:83-93.
41. Domes G., Heinrichs M., Kumbier E., Grossmann A., Hauenstein K., Herpertz S.C. Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder. Biological Psychiatry 2013, 74(3):164-171.
42. Domes G., Kumbier E., Heinrichs M., Herpertz S.C. Oxytocin promotes facial emotion recognition and amygdala reactivity in adults with Asperger syndrome. Neruopsychopharmacology 2014, 39(3):698-706.
43. Ellenbogen M.A., Linnen A.M., Cardoso C., Joober R. Intranasal oxytocin impedes the ability to ignore task-irrelevant facial expressions of sadness in students with depressive symptoms. Psychoneuroendocrinology 2013, 38(3):387-398.
44. Egawa J., Watanabe Y., Endo T., Tamura R., Masuzawa N., Someya T. Association between OXTR and clinical phenotypes of autism spectrum disorders. Psychiatry Research 2013, 208(1):99-100.
45. Feifel D., MacDonald K., Nguyen A., Cobb P., Warlan H., Galangue B., Minassian A., Becker O., Cooper J., Perry.W., Lefebvre M., Gonzales J., Hadley A. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biological Psychiatry 2010, 68(7):678-680.
46. Feldman R., Gordon I., Zagoory-Sharon O. Maternal and paternal plasma, salivary, and urinary oxytocin in and parent-infant synchrony: considering stress and affiliation components of human bonding. Developmental Science 2011, 14(4):752-761.
47. Fett A.K., Viechtbauer W., Dominquez M.D., Penn D.L., van Os J., Krabbendam L. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neuroscience and Biobehavioral Reviews 2011, 35(3):573-588.
48. Garety P., Freeman D. Cognitive approaches to delusion: A critical review of theories and evidence. British Journal of ClinicalPsychology 1999, 38:113-154.
49. Gainer H., Wray S. Cellular and Molecular Biology of Oxytocin and Vasopressin. The Physiology of Reproduction 1994, 1:1099-1130. Raven Press, New York. 2nd ed.
50. Gamer M., Zurowski B., Buchel C. Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:9400-9405.
51. Goldman M., Marlow-O'Connor M., Torres I., Carter C.S. Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits. Schizophrenia Research 2008, 98:247-255.
52. Goldman M.B. The mechanism of life-threatening water imbalance in schizophrenia and its relationship to the underlying psychiatric illness. Brain Research Review 2009, 61(2):210-220.
53. Goldman M.B., Gomes A.M., Carter C.S., Lee R. Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia. Psychopharmacology 2011, 216:101-110.
54. Gordon I., Zagoory-Sharon O., Leckman J.F., Feldman R. Oxytocin and the development of parenting in humans. Biological Psychiatry 2010, 68(4):377-382.
55. Gordon I., Vander Wyk B.C., Bennett R.H., Cordeaux C., Lucas M.V., Eilbott J.A., Zagoory-Sharon O., Leckmen J.F., Feldman R., Pelphrey K.A. Oxytocin enhances brain function in children with autism. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(52):20953-20958.
56. Green D.M., Swets J.A. Signal Detection Theory and Psychophysics 1966, Wiley and Sons, Inc., Los Altos, CA.
57. Green M.J., Phillips M.L. Social threat perception and the evolution of paranoia. Neuroscience and Biobehavioral Reviews 2004, 28:333-342.
58. Green M.F., Butler P.D., Chen Y., Geyer M.A., Silverstein S., Wynn J.K., Yoon J.H., Zemon V. Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS. Schizophrenia Bulletin 2009, 35(1):109-114.
59. Guastella A.J., Mitchell P.B., Mathews F. Oxytocin enhances the encoding of positive social memories in humans. Biological Psychiatry 2008, 64:256-258.
60. Guastella A.J., Howard A.L., Dadds M.R., Mitchell P., Carson D.S. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology 2009, 34:917-923.
61. Heim C., Nemeroff C.B. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biological Psychiatry 2001, 49:1023-1039.
62. Heim C., Young L.J., Newport D.J., Mletzko T., Miller A.H., Nemeroff C.B. Lower CSF oxytocin concentrations in women with a history of childhood abuse. Molecular Psychiatry 2009, 14:954-958.
63. Hoge E.A., Pollack M.H., Kaufman R.E., Zak P.J., Simon N.M. Oxytocin levels in social anxiety disorder. CNS Neuroscience and Therapeutics 2008, 14:165-170.
64. Hurlemann R., Patin A., Onur O.A., Cohen M.X., Baumgartner T., Metzler S., Dziobek I., Gallinat J., Wagner M., Maier W., Kendrick K.M. Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans. Journal of Neuroscience 2010, 30:4999-5007.
65. Insel T.R., O'Brien D.J., Leckman J.F. Oxytocin, vasopressin, and autism: is there a connection?. Biological Psychiatry 1999, 45(2):145-157.
66. Insel T.R., Young L.J. The neurobiology of attachment. Nature Reviews Neuroscience 2001, 2:129-136.
67. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. American Journal of Psychiatry 2003, 160:13-23.
68. Kirsch P., Esslinger C., Chen Q., Mier D., Lis S., Siddhanti S., Gruppe H., Mattay V.S., Gallhofer B., Meyer-Lindenberg A. Oxytocin modulates neural circuitry for social cognition and fear in humans. Journal of Neuroscience 2005, 25:11489-11493.
69. Kosfeld M., Heinrichs M., Zak P.J., Fischbacher U., Fehr E. Oxytocin increases trust in humans. Nature 2005, 435:673-676.
70. Kubzansky L.D., Mendes W.B., Appleton A.A., Block J., Adler G.K. A heartfelt response: oxytocin effects on response to social stress in men and women. Biological Psychology 2012, 90:1-9.
71. Labuschagne I., Phan K.L., Wood A., Angstadt M., Chua P., Heinrichs M. Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology 2010, 35:2403-2413.
72. Laviolette S.R. Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia?. Schizophrenia Bulletin 2007, 33:971-981.
73. Leknes S., Wessberg J., Ellingsen D.M., Chelnokova O., Olausson H., Laeng B. Oxytocin enhances pupil dilation and sensitivity to 'hidden' emotional expressions. Social Cognitive and Affective Neuroscience 2012, 8:741-749.
74. Light K.C., Grewen K.M., Amico J.A. More frequent partner hugs and higher oxytocin levels are linked to lower blood pressure and heart rate in premenopausal women. Biological Psychology 2005, 69(1):5-21.
75. Lin I.F., Kashino M., Ohta H., Yamada T., Tani M., Watanabe H., Kanai C., Ohno T., Takayama Y., Iwanami A., Kato N. The effect of intranasal oxytocin versus placebo treatment on the autonomic responses to human sounds in autism: a single-blind, randomized, placebo-controlled crossover design study. Molecular Autism 2014, 5(1):20.
76. Ludwig M., Leng G. Dendritic peptide release and peptide-dependent behaviours. Nature Reviews Neuroscience 2006, 7:126-136.
77. Luminet O., Grynberg D., Ruzette N., Mikolajczak M. Personality-dependent effects of oxytocin: greater social benefits for high alexithymia scorers. Biological Psychology 2011, 87(3):401-406.
78. Macdonald K., Feifel D. Oxytocin in schizophrenia: a review of evidence for its therapeutic effects. Acta Neuropsychiatry 2012, 24:130-146.
79. Malik A.I., Zai C.C., Abu Z., Nowrouzi B., Beitchman J.H. The role of oxytocin and oxytocin receptor gene variants in childhood-onset aggression. Genes, Brain and Behavior 2012, 11(5):545-551.
80. Marsh A.A., Yu H.H., Pine D.S., Blair R.J. Oxytocin improves specific recognition of positive facial expressions. Psychopharmacology 2010, 209:225-232.
81. Mathews A., MacLeod C. Cognitive vulnerability to emotional disorders. Annual Review of Clinical Psychology 2005, 1:167-195.
82. Montag C., Brockmann E.M., Lehmann A., Muller D.J., Rujescu D., Gallinat J. Association between oxytocin receptor gene polymorphisms and self-rated 'empathic concern' in schizophrenia. PLoS One 2012, 7:12.
83. Moritz S., Veckenstedt R., Bohn F., Kother U., Woodward T.S. Metacognitive Training in Schizophrenia: Theoretical Rationale and Administration. Social Cognition in Schizophrenia: From Evidence to Treatment 2013, Oxford University Press, New York. D.L. Roberts, D.L. Penn (Eds.).
84. Neumann I.D. Stimuli and consequences of dendritic release of oxytocin within the brain. Biochemical Society Transactions 2007, 35:1252-1257.
85. Ozsoy S., Esel E., Kula M. Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment. Psychiatry Research 2009, 13(3):249-252.
86. Pedersen C.A., Gibson C.M., Rau S.W., Salimi K., Smedley K.L., Casey R.L., Leserman J., Jarskog L.F., Penn D.L. Intranasal oxytocin reduces psychotic symptoms and improves theory of mind and social perception in schizophrenia. Schizophrenia Research 2011, 132:50-53.
87. Pinkham A.E., Penn D.L., Green M.F., Buck B., Healey K., Harvey P.D. The Social Cognition Psychometric (SCOPE) study: Results of the expert survey and RAND panel. Schizophrenia Bulletin 2014, 40:813-823.
88. Preti A., Melis M., Siddi S., Vellante M., Doneddu G., Fadda R. Oxytocin and autism: a systemic review of randomized controlled trials. Journal of Child and Adolescent Psychopharmocology 2014, 24(2):54-68.
89. Raskind M.A., Orenstein H., Christopher T.G. Acute psychosis, increased water ingestion, and inappropriate antidiuretic hormone secretion. American Journal of Psychiatry 1975, 132:907-910.
90. Roberts, D.L., Hillner, K., 2014. Using social cognitive training to improve functional outcome, in: Contribution to symposium entitled, Predicting Functional Outcome in Schizophrenia. Chair: A. Pinkham. Society for Psychopathology Conference, Evanston, IL.
91. Roberts D.L., Penn D.L., Combs D.R. Social Cognition and Interaction Training for schizophrenia: Treatment Manual 2014, (In press), Oxford University Press, New York.
92. Rosenfeld A.J., Lieberman J.A., Jarskog L.F. Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia. Schizophrenia Bulletin 2011, 37(5):1077-1087.
93. Rubin L.H., Carter C.S., Drogos L., Pournajafi-Nazarloo H., Sweeney J.A., Maki P.M. Peripheral oxytocin is associated with reduced symptom severity in schizophrenia. Schizophrenia Research 2010, 124:13-21.
94. Rubin L.H., Carter C.S., Drogos L., Jamadar R., Pournajafi-Nazarloo H., Sweeney J.A., Maki P.M. Sex-specific associations between peripheral oxytocin and emotion perception in schizophrenia. Schizophrenia Research 2011, 130:266-270.
95. Savaskan E., Erhardt R., Schulz A., Walter M., Schachinger H. Post-learning intranasal oxytocin modulates human memory for facial identity. Psychoneuroendocrinology 2008, 33(3):369-374.
96. Shamay-Tsoory S.G., Fischer M., Dvash J., Harari H., Perach-Bloom N., Levkovitz Y. Intranasal administration of oxytocin increases envy and schadenfreude (gloating). Biological Psychiatry 2009, 66(9):864-870.
97. Tost H., Kolachana B., Hakimi S., Lemaitre H., Verchinski B.A., Mattay V.S., Weinberger D.R., Meyer-Lindenberg A. A common allele in the oxytocin receptor gene (OXTR) impacts prosocial temperament and human hypothalamic-limbic structure and function. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:13936-13941.
98. Veenema A.H. Toward understanding how early-life social experiences alter oxytocin- and vasopressin-regulated social behaviors. Hormones and Behavior 2012, 61:304-312.
99. Vieweg W.V.R., Godleski L.S. Hyponatremia and atrial natriuretic peptide secretion in patients with vasopressin-induced antidiuresis (letter to the editor). American Journal of Medicine 1998, 85:594.
100. Winslow J., Noble P., Lyons C., Sterk S., Insel T. Rearing effects on cerebrospinal fluid oxytocin concentration and social buffering in rhesus monkeys. Neuropsychopharmacology 2003, 28:910-918.
101. Walss-Bass C., Fernandes J.M., Roberts D.L., Service H., Velligan D. Differential correlations between plasma oxytocin and social cognitive capacity and bias in schizophrenia. Schizophrenia Research 2013, 147(2-3):387-392.
102. Zak P.J., Stanton A.A., Ahmadi S. Oxytocin increases generosity in humans. PLoS One 2007, 2:e1128.
103. Zink C.F., Meyer-Lindenberg A. Human neuroimaging of oxytocin and vasopressin in social cognition. Hormones and Behavior 2012, 61:400-409.